PRF Technologies Ltd (PRFX)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

PRF Technologies Advances DeepSolar Predict™ Toward Commercial Launch as AI Platform Targets Revenue Optimization Across Renewable Energy Markets

TEL AVIV, Israel, May 28, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or the...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

PRF Technologies Announces PRF-110 Demonstrated Sustained 72-Hour Analgesic Activity Comparable to Approved, Commercially Available Benchmark in Head-to-Head Preclinical Study

TEL AVIV, Israel, May 26, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or the...

Form EFFECT - Notice of Effectiveness

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form F-1 - Registration statement for certain foreign private issuers

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

PRF Technologies Announces FDA Clearance of IND Application for OcuRing™-K Phase II Clinical Trial

TEL AVIV, Israel, April 28, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or the...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

PRF Technologies Provides Year-End 2025 Business Update Highlighting Strategic Progress Across Healthcare and AI-Driven Solar Platforms

LayerBio’s OcuRing™-K program and broader ocular platform strengthen PRF’s healthcare growth strategy...

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 3 - Initial statement of beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities